C-Ray Therapeutics (Chengdu) Co., Ltd Congratulates Partner Biokin Pharmaceutical on NMPA IND Approval of First Proprietary ARC Drug [177Lu]-BL-ARC001 TrendingStockAlerts · Oct 13, 2025
Development of the First Inner Ear Organoids by 3D Bioprinting for Pharmacological Screening in Hearing Disorders: CTIBIOTECH™ Announces Strategic Agreement With SATT AxLR and CILCARE TrendingStockAlerts · Oct 12, 2025
Alamar Biosciences Launches NULISAqpcr™ BD-pTau217 Assay: A Breakthrough in Non-Invasive, Brain-Specific Biomarker Detection for Alzheimer's Disease Research TrendingStockAlerts · Oct 11, 2025
Chance Pharma Announces Commercialization Agreement with Huadong Medicine for Innovative Respiratory Drug CXG87 TrendingStockAlerts · Oct 10, 2025
Complement Therapeutics Receives FDA IND Clearance to Advance CTx001 into Opti-GAIN, a Phase I/II Clinical Trial in Geographic Atrophy secondary to AMD TrendingStockAlerts · Oct 9, 2025
Beactica conducts first advisory meeting with the Swedish Medical Products Agency regarding the development of BEA-17 TrendingStockAlerts · Oct 8, 2025
HanchorBio Announces Acceptance of HCB301 Abstract for Poster Presentation at SITC 2025 Annual Meeting TrendingStockAlerts · Oct 5, 2025
Nutromics unveils world-first real-time in vivo multiplexing data at IATDMCT TrendingStockAlerts · Oct 4, 2025
Pacific Northwest Research Institute Publishes Key Advances in Rare and Genetic Disease Research Amid National Funding Uncertainty TrendingStockAlerts · Oct 3, 2025
AbbVie Begins Construction on $70 Million Expansion to Further Increase Biologics Manufacturing and R&D Presence in the U.S. TrendingStockAlerts · Oct 2, 2025
